Erratum: Immunotherapy for Glioblastoma: Current Progress and Challenges

DOI: https://doi.org/10.3389/fimmu.2021.782687

IF: 7.3

2021-10-07

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2021.676301.].

immunology

What problem does this paper attempt to address?

Erratum: First step results from a phase II study of a dendritic cell vaccine in glioblastoma patients (CombiG-vax)

Frontiers Production Office

DOI: https://doi.org/10.3389/fimmu.2024.1494021

2024-09-19

Abstract:[This corrects the article DOI: 10.3389/fimmu.2024.1404861.].
Erratum: Overcoming immune resistance with radiation therapy in prostate cancer

DOI: https://doi.org/10.3389/fimmu.2023.1185185

IF: 7.3

2023-03-23

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.859785.].

immunology
Erratum: γδ T cells as immunotherapy for malaria: balancing challenges and opportunities

Frontiers Production Office

DOI: https://doi.org/10.3389/fimmu.2024.1364914

IF: 7.3

2024-01-11

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2023.1242306.].

immunology
Erratum: Investigating tumor immunogenicity in breast cancer: deciphering the tumor immune response to enhance therapeutic approaches

Frontiers Production Office

DOI: https://doi.org/10.3389/fimmu.2024.1532921

IF: 7.3

2024-12-12

Frontiers in Immunology

Abstract:This article is an erratum on: Investigating tumor immunogenicity in breast cancer: deciphering the tumor immune response to enhance therapeutic approaches

immunology
Corrigendum: Establishment and immune phenotyping of patient-derived glioblastoma models in humanized mice

Longsha Liu,Thijs A van Schaik,Kok-Siong Chen,Filippo Rossignoli,Paulo Borges,Vladimir Vrbanac,Hiroaki Wakimoto,Khalid Shah

DOI: https://doi.org/10.3389/fimmu.2024.1466387

2024-08-05

Abstract:[This corrects the article DOI: 10.3389/fimmu.2023.1324618.].
Erratum: Molecular Biomarkers of Response to PD-1/ PD-L1 Immune Checkpoint Blockade in Advanced Bladder Cancer

DOI: https://doi.org/10.3233/BLC-219500

2021-03-19

Bladder Cancer

Abstract:[This corrects the article DOI: 10.3233/BLC-200013.].
Erratum: Approaching hemophagocytic lymphohistiocytosis

Frontiers Production Office

DOI: https://doi.org/10.3389/fimmu.2024.1369687

IF: 7.3

2024-01-22

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2023.1210041.].

immunology
Erratum: The efficacy of cancer immunotherapies is compromised by Helicobacter pylori infection

DOI: https://doi.org/10.3389/fimmu.2023.1183107

IF: 7.3

2023-03-21

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.899161.].

immunology
Corrigendum: Tumor-Associated Macrophages in Tumor Immunity

Yueyun Pan,Yinda Yu,Xiaojian Wang,Ting Zhang

DOI: https://doi.org/10.3389/fimmu.2021.775758

IF: 7.3

2021-01-01

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2020.583084.].
Erratum: IGF2BP family of RNA-binding proteins regulate innate and adaptive immune responses in cancer cells and tumor microenvironment

Frontiers Production Office

DOI: https://doi.org/10.3389/fimmu.2023.1297519

IF: 7.3

2023-09-27

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2023.1224516.].

immunology
Erratum: Dual inhibition of PFKFB3 and VEGF normalizes tumor vasculature, reduces lactate production, and improves chemotherapy in glioblastoma: insights from protein expression profiling and MRI: Erratum

Junfeng Zhang,Wei Xue,Kai Xu,Liang Yi,Yu Guo,Tian Xie,Haipeng Tong,Bo Zhou,Shunan Wang,Qing Li,Heng Liu,Xiao Chen,Jingqin Fang,Weiguo Zhang

DOI: https://doi.org/10.7150/thno.92042

IF: 11.6

2023-11-17

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.44427.].
Erratum: Immunoregulatory Effects of Myeloid-Derived Suppressor Cell Exosomes in Mouse Model of Autoimmune Alopecia Areata

Frontiers Production Office

DOI: https://doi.org/10.3389/fimmu.2021.832980

IF: 7.3

2021-12-24

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2018.01279.].

immunology
Erratum: Mechanisms of extracellular vesicle-mediated immune evasion in melanoma

DOI: https://doi.org/10.3389/fimmu.2023.1178158

IF: 7.3

2023-03-13

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.1002551.].

immunology
Erratum: Author correction to '3- O-Acetyl-11-keto- β-boswellic acid ameliorated aberrant metabolic landscape and inhibited autophagy in glioblastoma' [Acta Pharm Sin B 10 (2020) 301-312]

Wan Li,Liwen Ren,Xiangjin Zheng,Jinyi Liu,Jinhua Wang,Tengfei Ji,Guanhua Du

DOI: https://doi.org/10.1016/j.apsb.2024.04.025

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2019.12.012.].
Erratum: Preoperative immunological plasma markers TRAIL, CSF1, and TIE2 predict survival after resection for biliary tract cancer

Frontiers Production Office

DOI: https://doi.org/10.3389/fonc.2023.1281693

2023-09-27

Abstract:[This corrects the article DOI: 10.3389/fonc.2023.1169537.].
Correction to: Recurrent fibroblast growth factor receptor3 fusion glioblastoma treated with pemigatinib: A case report and review of the literature

DOI: https://doi.org/10.1093/noajnl/vdae116

2024-07-08

Abstract:[This corrects the article DOI: 10.1093/noajnl/vdae072.].
Erratum: Trends in the global immuno-oncology landscape

Jun Tang,Laura Pearce,Jill O'Donnell-Tormey,Vanessa M. Hubbard-Lucey

DOI: https://doi.org/10.1038/nrd.2018.202

IF: 112.288

2018-01-01

Nature Reviews Drug Discovery

Abstract:Nature Reviews Drug Discovery 17, 783–784 (2018) In the original version of Figure 1, the label in the Y axis 'T cell-targeted' was incorrect and should be 'T cell-targeted immunomodulator'. The article has been corrected in the online version.
Erratum: ITGA2 Overexpression Promotes Esophageal Squamous Cell Carcinoma Aggression via FAK/AKT Signaling Pathway [Corrigendum]

DOI: https://doi.org/10.2147/OTT.S390829

2022-09-27

Abstract:[This corrects the article DOI: 10.2147/OTT.S302028.].
Erratum: Efficacy and safety evaluations of anlotinib in patients with advanced non-small cell lung cancer treated with bevacizumab

Frontiers Production Office

DOI: https://doi.org/10.3389/fphar.2022.1092147

IF: 5.6

2022-11-22

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2022.973448.].

pharmacology & pharmacy
Erratum: Targeting Telomere Dynamics as an Effective Approach for the Development of Cancer Therapeutics [Corrigendum]

DOI: https://doi.org/10.2147/IJN.S500182

2024-10-14

Abstract:[This corrects the article DOI: 10.2147/IJN.S448556.].

Erratum: Immunotherapy for Glioblastoma: Current Progress and Challenges

Erratum: First step results from a phase II study of a dendritic cell vaccine in glioblastoma patients (CombiG-vax)

Erratum: Overcoming immune resistance with radiation therapy in prostate cancer

Erratum: γδ T cells as immunotherapy for malaria: balancing challenges and opportunities

Erratum: Investigating tumor immunogenicity in breast cancer: deciphering the tumor immune response to enhance therapeutic approaches

Corrigendum: Establishment and immune phenotyping of patient-derived glioblastoma models in humanized mice

Erratum: Molecular Biomarkers of Response to PD-1/ PD-L1 Immune Checkpoint Blockade in Advanced Bladder Cancer

Erratum: Approaching hemophagocytic lymphohistiocytosis

Erratum: The efficacy of cancer immunotherapies is compromised by Helicobacter pylori infection

Corrigendum: Tumor-Associated Macrophages in Tumor Immunity

Erratum: IGF2BP family of RNA-binding proteins regulate innate and adaptive immune responses in cancer cells and tumor microenvironment

Erratum: Dual inhibition of PFKFB3 and VEGF normalizes tumor vasculature, reduces lactate production, and improves chemotherapy in glioblastoma: insights from protein expression profiling and MRI: Erratum

Erratum: Immunoregulatory Effects of Myeloid-Derived Suppressor Cell Exosomes in Mouse Model of Autoimmune Alopecia Areata

Erratum: Mechanisms of extracellular vesicle-mediated immune evasion in melanoma

Erratum: Author correction to '3- O-Acetyl-11-keto- β-boswellic acid ameliorated aberrant metabolic landscape and inhibited autophagy in glioblastoma' [Acta Pharm Sin B 10 (2020) 301-312]

Erratum: Preoperative immunological plasma markers TRAIL, CSF1, and TIE2 predict survival after resection for biliary tract cancer

Correction to: Recurrent fibroblast growth factor receptor3 fusion glioblastoma treated with pemigatinib: A case report and review of the literature

Erratum: Trends in the global immuno-oncology landscape

Erratum: ITGA2 Overexpression Promotes Esophageal Squamous Cell Carcinoma Aggression via FAK/AKT Signaling Pathway [Corrigendum]

Erratum: Efficacy and safety evaluations of anlotinib in patients with advanced non-small cell lung cancer treated with bevacizumab

Erratum: Targeting Telomere Dynamics as an Effective Approach for the Development of Cancer Therapeutics [Corrigendum]